PE: CRI - Cancer Research Institute: Cellular Therapies: TIL, TCR, CAR T, and NK Cell Therapies
Patient Education: Reading
Updated: May 9, 2022
PE: CRI - Cancer Research Institute: Cellular Therapies: TIL, TCR, CAR T, and NK Cell Therapies

How Cellular Immunotherapies Are Changing the Outlook for Cancer Patients
Adoptive Cell Therapy
TIL, TCR, CAR T, and NK Cell Therapies
Adoptive cell therapy, also known as cellular immunotherapy, is a form of treatment that uses the cells of our immune system to eliminate cancer.
Types of Cellular immunotherapies:
Tumor-Infiltrating Lymphocyte (TIL) Therapy
Engineered T Cell Receptor (TCR) Therapy
Chimeric Antigen Receptor (CAR) T Cell Therapy
Natural Killer (NK) Cell Therapy
Learn more: